Budget Amount *help |
¥17,420,000 (Direct Cost: ¥13,400,000、Indirect Cost: ¥4,020,000)
Fiscal Year 2018: ¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
Fiscal Year 2017: ¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2016: ¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2015: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
|
Outline of Final Research Achievements |
To explore the novel pathogenesis and pathophysiology of epilepsy, schizophrenia, attention-deficit hyperactivity disorder (ADHD) and dementia, the present study determined the functional abnormalities of tripartite synaptic transmission using in vivo microdialysis and primary cultured astrocytes. The results of this study suggest that the enhancement of astroglial glutamate/cystine antiporter and metabotropic glutamate receptor contribute to the pathophysiology of epilepsy, schizophrenia, ADHD and dementia.
|